Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of different doses of olmesartan medoxomil compared to losartan on proteinuria, renal function and inflammatory markers in type 2 diabetics with nephropathy

Trial Profile

Effect of different doses of olmesartan medoxomil compared to losartan on proteinuria, renal function and inflammatory markers in type 2 diabetics with nephropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2008

At a glance

  • Drugs Losartan; Olmesartan medoxomil
  • Indications Diabetic nephropathies; Hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2004.
    • 03 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top